Holen Sie sich die Stockscreener-App
1.32
2.22%
-0.03
Handel nachbörslich:
1.32
Schlusskurs vom Vortag:
$1.35
Offen:
$1.37
24-Stunden-Volumen:
215.81K
Relative Volume:
0.44
Marktkapitalisierung:
$59.23M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-1.2692
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+11.86%
1M Leistung:
+2.33%
6M Leistung:
-11.41%
1J Leistung:
-33.67%
1-Tages-Spanne:
$1.31
$1.39
1-Wochen-Bereich:
$1.12
$1.39
52-Wochen-Spanne:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.32 | 60.58M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
Is Werewolf Therapeutics Inc. in a bullish channel2025 Dividend Review & Free Risk Controlled Daily Trade Plans - sundaytimes.kr
When is the best time to exit Werewolf Therapeutics Inc.Market Growth Report & Community Consensus Picks - Newser
Werewolf Therapeutics Reports Q2 2025 Financial Results - TipRanks
Custom watchlist performance reports with Werewolf Therapeutics Inc.Portfolio Performance Report & Long Hold Capital Preservation Plans - Newser
Werewolf Reports No Revenue in Fiscal Q2 - The Motley Fool
Werewolf Therapeutics, Inc. SEC 10-Q Report - TradingView
Werewolf Therapeutics: Capitalizing on Immuno-Oncology Innovation with a Strategic Path to Commercialization - AInvest
Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Using data filters to optimize entry into Werewolf Therapeutics Inc.July 2025 Intraday Action & Daily Chart Pattern Signals - Newser
Using data models to predict Werewolf Therapeutics Inc. stock movementExit Point & Intraday High Probability Setup Alerts - Newser
Why Werewolf Therapeutics Inc. is moving todayJuly 2025 Closing Moves & Safe Entry Point Identification - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potential2025 Bull vs Bear & Precise Swing Trade Entry Alerts - Newser
Relative strength of Werewolf Therapeutics Inc. in sector analysisJuly 2025 Big Picture & Safe Entry Momentum Tips - Newser
Key metrics from Werewolf Therapeutics Inc.’s quarterly dataQuarterly Trade Summary & Trade Opportunity Analysis Reports - Newser
Published on: 2025-08-13 22:40:57 - 선데이타임즈
Smart tools for monitoring Werewolf Therapeutics Inc.’s price actionJuly 2025 Weekly Recap & Fast Entry and Exit Trade Plans - Newser
Understanding Werewolf Therapeutics Inc.’s price movementMarket Rally & Free Community Supported Trade Ideas - Newser
Strategies to average down on Werewolf Therapeutics Inc.Quarterly Profit Report & Daily Market Momentum Tracking - Newser
Real time alert setup for Werewolf Therapeutics Inc. performanceTrade Volume Summary & AI Enhanced Trading Alerts - Newser
Analyzing Werewolf Therapeutics Inc. with risk reward ratio chartsAI-Based Signal Detection for Active Traders - Newser
Werewolf Therapeutics Inc. stock momentum explained [Recession Risk]AI Forecasted Entry and Exit Points - Newser
Visual analytics tools that track Werewolf Therapeutics Inc. performanceQuarterly Earnings Summary & Community Supported Trade Ideas - Newser
Can swing trading help recover from Werewolf Therapeutics Inc. lossesHigh Conviction Stock Long-Term Summary - Newser
Analyzing Werewolf Therapeutics Inc. with multi timeframe chartsStrong Buy Opportunity with Volume Support - Newser
How institutional ownership impacts Werewolf Therapeutics Inc. stockLong Term Stock Planner with Safety Checks - Newser
Short interest data insights for Werewolf Therapeutics Inc.Free Smart Allocation Stock Pick Insights - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategiesLong-Term Allocation Strategy Summary Breakdown - Newser
Full technical analysis of Werewolf Therapeutics Inc. stockBuy Zone Strategy with Pattern Recognition - Newser
Short Term Charts Align With Long Term Uptrend in Werewolf Therapeutics Inc.AI Driven Buy Alert Trade Blueprint Released - beatles.ru
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionDividend Strategy Summary With 10-Year Outlook - Newser
What makes Werewolf Therapeutics Inc. stock price move sharplyTop Stock Picks with Forecast Accuracy - Newser
Werewolf Therapeutics Inc. stock momentum explainedEarly Buy Opportunity with Chart Triggers - Newser
What machine learning models say about Werewolf Therapeutics Inc.Earnings Report Summary with Market Impact - Newser
How Werewolf Therapeutics Inc. stock performs during market volatilityPredictable Return Strategy with AI Support - Newser
Werewolf Therapeutics Inc. stock outlook for YEARAI Generated Momentum Stock Forecast Guide - Newser
Werewolf Therapeutics (HOWL) Projected to Post Earnings on Thursday - Defense World
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):